Navigation Links
Dendreon Reports First Quarter 2009 Financial Results
Date:5/6/2009

  • Presented data from the PROTECT (PROvenge Treatment and Early Cancer Treatment) or P-11 Phase 3 study suggesting that PROVENGE induces long-term memory immune responses that are durable and can be maintained following boosting. The results of the study also indicate that CD54 upregulation on Antigen Presenting Cells (APC), a measure of product potency, is a correlate of immune activation. P-11 is an ongoing Phase 3 clinical trial designed to evaluate the safety and biologic activity of PROVENGE in patients with non-metastatic androgen-dependent (hormone sensitive) prostate cancer who have had a prostate-specific antigen (PSA) recurrence following surgical removal of the prostate.

  • "The significant increase in overall survival demonstrated in our Phase 3 IMPACT trial for PROVENGE is a major milestone for the company and puts us one step closer to making PROVENGE available to patients with prostate cancer who currently have few appealing treatment options," stated Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "We look forward to reviewing our commercialization plans for PROVENGE in more detail during a webcast analyst day this summer."

    In lieu of a conference call, the Company will present at several upcoming investor conferences that will be webcast, three of which are later this month and include:

    • Bank of America / Merrill Lynch 2009 Health Care Conference on May 12, 2009
    • Deutsche Bank 34th Annual Healthcare Conference on May 19, 2009
    • Leerink Swann Novel Cancer Therapeutics: Roundtable Conference on May 20, 2009

    About Dendreon

    Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel th
    '/>"/>

    SOURCE Dendreon Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
    2. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
    3. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
    4. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
    5. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
    6. Dendreon Reports Third Quarter 2008 Financial Results
    7. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
    8. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
    9. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
    10. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
    11. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... -- The Alliance for Safe Biologic Medicines ... physicians at the "1 ST EuropaBio – ... the Spanish Ministry of Health, Social Services and ... Spanish Bioindustry Association (ASEBIO), included regulators from the ... and rheumatology societies, representatives from a hospital pharmacist ...
    (Date:11/26/2014)... 2014 The ETC (Emerging Technology ... innovation centers, announced today that applications for AccelerateBaltimore™ ... 1st. “Do you have a big idea?,” asked ... to know about it. AccelerateBaltimore helps you and ... in just 13 weeks.” Interested game changers ...
    (Date:11/26/2014)... Morristown, NJ (PRWEB) November 25, 2014 ... it has officially joined the Morris County (New ... MCCC, which is a leading business organization in ... unique opportunity to further engage some key clients ... have operations in the geographic area. Membership enables ...
    (Date:11/26/2014)... Silicon Valley Electronic Data Capture (EDC) provider ... , provider of clinical research and data management services ... to its CRO Partnership Program, Clinovo expands ClinCapture ... , “We have found Clinovo’s ClinCapture to exceed ... which is both user friendly and easy to deploy. ...
    Breaking Biology Technology:ASBM Presents European Physicians Survey at Spanish Ministry of Health 2AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2
    ... Fla. , Jan. 15 Andrew P. ... Foundation and diabetes advocate announced today that he will be ... a biotechnology company that has developed and patented a family ... and cosmetic industries. , "I,m really excited about their ...
    ... , Jan. 14 /PRNewswire-FirstCall/ - Medical International Technology Inc. ... that it has received clearance by FINRA to be traded on ... posted for trading on the OTC Bulletin Board at the opening ... MDLH.OB. , This is very positive news for all existing and ...
    ... ... Scholarships. The first is a two-year scholarship to be awarded to a graduating ... sponsor four scholarships for community-active, graduating Lake Braddock High School seniors. , ... Manassas, VA (PRWEB) January 13, ...
    Cached Biology Technology:Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board 2MIT is pleased to announce that it has received clearance by FINRA to be listed on the OTC Bulletin Board "MDLH.OB" 2RiVIdium Inc. Creates Five Local Scholarships 2
    (Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
    (Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
    (Date:11/11/2014)...  Forensicon, Inc., a Chicago -based ... the promotion of Yaniv Schiff from Senior ... Schiff,s new role as Director, he will lead company ... examiners and provide leadership within the company,s digital forensics ... Schiff joined Forensicon in 2006 ...
    Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
    ... and the Montreal Neurological Institute (MNI), McGill University have ... survival also play an active and major role in ... published this week in The Journal of Neuroscience ... variety of acute and chronic neurological disorders, including glaucoma ...
    ... impact on them caused by humanity,s carbon emissions. ... used coral from the Great Barrier Reef to reveal ... due to human activity. Professor Malcolm McCulloch, a ... Reef Studies and Australian National University today receives Australia,s ...
    ... (Nasdaq: AWRE ), a leading supplier of broadband ... first quarter ended March 31, 2009. Revenues for the ... 22% compared to $5.9 million in the same quarter last ... diluted net income per share in accordance with U.S. generally ...
    Cached Biology News:Cell's split personality is a major discovery into neurological diseases 2Coral 'can't escape the heat' 2Aware, Inc. Reports First Quarter 2009 Financial Results 2Aware, Inc. Reports First Quarter 2009 Financial Results 3Aware, Inc. Reports First Quarter 2009 Financial Results 4Aware, Inc. Reports First Quarter 2009 Financial Results 5Aware, Inc. Reports First Quarter 2009 Financial Results 6
    ... Synthetic peptide derived from the C terminal ... This peptide sequence is downstream from ... polyclonal Connexin 36 antibody Cat. No. 51-6300. ... Reactivity: Mouse (positive control: mouse Connexin ...
    ...
    ...
    ...
    Biology Products: